Synthetic Porcine Secretin

About ChiRhoClin

Founded in 1991 by Dr. Edward D. Purich, ChiRhoClin is a specialized pharmaceutical company dedicated to orphan theranostics for gastrointestinal and pancreatic disorders. Its core achievement is the FDA approval and commercialization of ChiRhoStim® (Synthetic Human Secretin), used in diagnostic pancreatic function tests and to facilitate endoscopic retrograde cholangiopancreatography (ERCP). The company maintains a research-oriented culture, supports academic research through grant programs, and collaborates with major medical institutions on ongoing clinical studies in pancreatic cancer and pancreatitis.

Therapeutic Areas

Other Diagnostic and Therapeutic Applications Drugs